Failure of Another Trial Testing Guided Antiplatelet Therapy Prompts Debate, Lancet Reveals

Published: Apr 09, 2012

Yet another trial has failed to prove the hypothesis that guided antiplatelet therapy with platelet function testing or genetic testing improves outcomes. Although there has been no public announcement so far, the TARGET-PCI (Thrombocyte Activity Reassessment and GEnoTyping for PCI) was suspended last October, according to the TARGET-PCI page on ClinicalTrials.Gov.

Back to news